Arca
Skip to content

Nova Primary Glucose Analyzer System

Glucose Oxidase, Glucose. 510(k) K203549, from Nova Biomedical Corporation (Waltham, ME). Product code CGA, class 2.

As of Nov 17, 2026, K203549 is an FDA 510(k) held by Nova Biomedical Corporation, substantially equivalent on Oct 18, 2022 after 683 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Oct 18, 2022
  • Review time: 683 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Nova Primary Glucose Analyzer System is indicated for in vitro diagnostic use by healthcare professionals in clinical laboratory setting for the quantitative determination of Glucose in lithium heparinized venous whole blood and plasma.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other CGA Clearances

The newest 510(k)s for the same product code; their median review was 266 days; see every CGA device

Record

Type
Traditional
Received
Dec 4, 2020
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1345

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.